Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.590
-0.050 (-1.08%)
At close: Sep 5, 2025, 4:00 PM
4.560
-0.030 (-0.65%)
After-hours: Sep 5, 2025, 4:43 PM EDT

Vanda Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts that cover Vanda Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $16.5, which forecasts a 259.48% increase in the stock price over the next year. The lowest target is $13 and the highest is $20.

Price Target: $16.5 (+259.48%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$13$16.5$20$20
Change+183.22%+259.48%+335.73%+335.73%

Analyst Ratings

The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy111111
Buy122211
Hold000000
Sell000000
Strong Sell000000
Total233322

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+335.73%Aug 21, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$13
BuyInitiates$13+183.22%May 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+335.73%May 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong BuyReiterates$20+335.73%Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$18$20
Strong BuyMaintains$18$20+335.73%Feb 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
229.48M
from 198.77M
Increased by 15.45%
Revenue Next Year
316.27M
from 229.48M
Increased by 37.82%
EPS This Year
-1.84
from -0.33
EPS Next Year
-1.06
from -1.84
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
248.17M268.68M254.38M192.64M198.77M229.48M316.27M
Revenue Growth
9.24%8.27%-5.32%-24.27%3.18%15.45%37.82%
EPS
0.420.580.110.04-0.33-1.84-1.06
EPS Growth
-80.10%38.10%-81.03%-63.64%---
Forward PE
-------
No. Analysts
-----55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High239.4M336.0M
Avg229.5M316.3M
Low215.9M290.4M

Revenue Growth

Revenue Growth202520262027
High
20.4%
46.4%
Avg
15.4%
37.8%
Low
8.6%
26.5%

EPS Forecast

EPS202520262027
High-1.540.05
Avg-1.84-1.06
Low-2.10-1.75

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.